Remus Pharmaceuticals (NSE:REMUS) EPS (Basic) : ₹65.21 (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals EPS (Basic)?

Remus Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was ₹41.43. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹65.21.

Remus Pharmaceuticals's EPS (Diluted) for the six months ended in Mar. 2025 was ₹41.43. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹65.21.

Remus Pharmaceuticals's EPS without NRI for the six months ended in Mar. 2025 was ₹41.43. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 65.21.

During the past 12 months, Remus Pharmaceuticals's average EPS without NRIGrowth Rate was 51.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 244.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Remus Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 244.00% per year. The lowest was 214.80% per year. And the median was 229.40% per year.

Remus Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Remus Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals EPS (Basic) Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Mar25

EPS (Basic)

1.38

1.74

5.75

42.97

65.21

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24	Mar25
EPS (Basic)	Get a 7-Day Free Trial			-	10.38	32.59	23.78	41.43

Remus Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Remus Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(290.7	-	0)	/	4.458
	=	65.21

Remus Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(150.588	-	0)	/	4.458
	=	33.78

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹65.21

Remus Pharmaceuticals (NSE:REMUS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Remus Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines